Start Date
November 30, 2006
Study Completion Date
November 30, 2009
ADH -1 and carboplatin
ADH -1 and docetaxel
ADH -1 and capecitabine
New York Oncology Hematology P.C., Albany
Virginia Oncology Associates, Norfolk
Cancer Centers of the Carolinas, Greenville
Cancer Centers of Florida, Ocoee
Dayton Oncology & Hematology, P.A, Kettering
Central Indiana Cancer Centers, Indianapolis
Texas Oncology, PA, Dallas
Tyler Cancer Center, Tyler
Rocky Mountain Cancer Centers, Denver
Northwest Cancer Specialists - Vancouver Cancer Center, Vancouver
Lead Sponsor
US Oncology Research
INDUSTRY
Adherex Technologies, Inc.
INDUSTRY